COMMUNIQUÉS West-GlobeNewswire

23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
31/01/2024
23ME-01473 (‘1473) seeks to treat cancer by restoring anti-tumor immunity through NK and T cells ‘1473 has dual mechanisms of blocking the immunosuppressive effects of soluble ULBP6, and inducing Fc receptor-mediated [...]
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024
PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced [...]
Protara Therapeutics to Participate in Upcoming Investor Conferences
31/01/2024
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
Agrify Receives Positive Nasdaq Listing Determination
31/01/2024
TROY, Michigan, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today [...]
Biogen to Realign Resources for Alzheimer's Disease Franchise
31/01/2024
Company to reprioritize resources allocated to ADUHELM ® (aducanumab-avwa) to advance LEQEMBI ® (lecanemab-irmb) and to develop new treatment modalities Biogen committed to building a leading Alzheimer’s disease [...]
Plus de capacités en faveur des clients : Olon va ouvrir une nouvelle unité de production d'IPA hautement actifs aux États-Unis
31/01/2024
MILAN, Italie, 31 janv. 2024 (GLOBE NEWSWIRE) -- Le groupe Olon annonce la construction d'une unité de production de pointe d'ingrédients pharmaceutiques actifs (IPA) hautement actifs. L'unité de production d' [...]
Trinity Biotech Announces Q3 2023 Financial Results & Business Update
31/01/2024
-Investor call to be held today at 8:30 am EST DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company’s results for the quarter ended September 30, 2023. [...]
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India
31/01/2024
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the launch of a Continuous [...]
SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024
STAMFORD, Conn., Jan. 31, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management [...]
Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science
31/01/2024
Partnership represents firm’s second international collaboration and provides access to groundbreaking research taking place within world’s fifth largest pharmaceutical market CINCINNATI, Jan. 31, 2024 (GLOBE NEWSWIRE [...]
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
31/01/2024
PETACH TIKVA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report [...]
EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024
WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal [...]
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
31/01/2024
BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Tango Therapeutics , Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today [...]
Tilray Beers: A Lock for the Big Game
31/01/2024
Tilray’s Fan-Favorite Breweries Have Big Game Beers for the Biggest Football Game of the Year NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- As football fans gear up for the biggest showdown of the year, Tilray Brands , (" [...]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
31/01/2024
BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management [...]
NC AMVETS Service Foundation Launches CBD Study for Veterans with University of Northern Colorado and Vantage Hemp Co.
31/01/2024
National research initiative will uncover insights into CBD efficacy and advocate for America’s veterans Rockwell, North Carolina, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The North Carolina AMVETS Service Foundation , a 501(c [...]
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
31/01/2024
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million cash and 9 million [...]
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
31/01/2024
VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage pharmaceutical development [...]
Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID
31/01/2024
Retrospective observational study of electronic medical records of more than 90 million people living in the U.S. Long COVID shares symptoms with chronic overlapping pain disorders like fibromyalgia and appears [...]

Pages